E. Gerald Kay

2022

In 2022, E. Gerald Kay earned a total compensation of $286.4K as Executive Chairman and President at Integrated Biopharma.

Compensation breakdown

Option Awards$33,651
Salary$215,693
Other$37,036
Total$286,380

Kay received $215.7K in salary, accounting for 75% of the total pay in 2022.

Kay also received $33.7K in option awards and $37K in other compensation.

Rankings

In 2022, E. Gerald Kay's compensation ranked 5,087th out of 5,669 executives tracked by ExecPay. In other words, Kay earned more than 10.3% of executives.

ClassificationRankingPercentile
All
5,087
out of 5,669
10th
Division
Manufacturing
2,795
out of 3,081
9th
Major group
Chemicals And Allied Products
1,299
out of 1,396
7th
Industry group
Drugs
1,220
out of 1,297
6th
Industry
Pharmaceutical Preparations
884
out of 940
6th
Source: SEC filing on October 27, 2023.

Kay's colleagues

We found four more compensation records of executives who worked with E. Gerald Kay at Integrated Biopharma in 2022.

2022

Dina Masi

Integrated Biopharma

Chief Financial Officer

2022

EGerald Kay

Integrated Biopharma

Chairman

2022

Riva Sheppard

Integrated Biopharma

Chief Executive Officer

2022

Christina Kay

Integrated Biopharma

Chief Executive Officer

News

You may also like